logo

For the Inventor, By the Inventor

Kawanishi, Japan

Akinobu Nagaoka

This inventor holds 14 USPTO granted patents, plus 3 CIPO patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1984-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akinobu Nagaoka. Retrieved from https://idiyas.com/inventor/akinobu-nagaoka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 100.0


Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 133(Granted Patents)


Location History:

  • Kawanishi, JP (1984 - 1999)
  • Hyogo, JP (1989 - 1999)

Company Filing History:

goldMedal14 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1984-1999

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 5965568 - Composition for inhibiting production or secretion of amyloid .beta. (1999-10-12),
2. 5916925 - Pharmaceutical composition for treatment of dementia (1999-06-29),
3. 5604210 - Inhibitor of vascular permeability enhancer (1997-02-18),
4. 5434179 - Method for improving brain function using cholinesterase-inhibiting (1995-07-18),
5. 5180746 - Aralkylamine compounds (1993-01-19),
6. 5169856 - Piperidinoalkyl derivatives of carboxylic acid amides (1992-12-08),
7. 5025033 - Alkylene diamines (1991-06-18),
8. 5021439 - Cerebral function ameliorating agents related to Tan-950 A (1991-06-04),
9. 4892875 - Substituted heterocyclylalkyl esters of (1990-01-09),
10. 4824848 - Pyrazolo[3,4-d]pyrimidine derivatives, their production and use (1989-04-25),
11. 4804665 - Azaspiro compounds and their use (1989-02-14),
12. 4748154 - Peptide derivatives, their production and use (1988-05-31),
13. 4603135 - Substituted piperazinyl alkyl esters of (1986-07-29),
14. 4436753 - Method for therapy of ischemic disease (1984-03-13),

Title: Akinobu Nagaoka: Innovating the Future of Dementia Treatment

Introduction

Akinobu Nagaoka is a notable inventor based in Kawanishi, Japan, recognized for his significant contributions to medical innovations. With a remarkable portfolio of 14 patents, he has been at the forefront of developing pharmaceutical compositions aimed at treating dementia and related neurological conditions.

Latest Patents

His latest patents include groundbreaking work on a composition for inhibiting the production or secretion of amyloid beta, a key factor in the progression of Alzheimer's disease. Additionally, he has developed a pharmaceutical composition that employs idebenone, which is particularly useful for preventing the progression of dementia.

Career Highlights

Currently, Akinobu Nagaoka is employed at Takeda Chemical Industries, a well-respected organization in the pharmaceutical field. His work focuses on innovative solutions that can potentially alter the landscape of dementia treatment, making strides toward improving the quality of life for those affected by this condition.

Collaborations

Throughout his career, Nagaoka has had the privilege of collaborating with distinguished coworkers such as Giichi Goto and Kanji Meguro. These partnerships foster a creative environment that encourages the exchange of ideas and enhances the development of effective therapeutic solutions.

Conclusion

Akinobu Nagaoka stands as a prominent figure in the field of pharmaceutical innovation. His dedication to advancing treatments for dementia through his robust patent portfolio underscores his commitment to improving both medical understanding and patient care. As he continues to innovate, the future looks promising for both his research and the patients who stand to benefit from his work.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…